New treatment option for endometrial cancer shows promise in phase II trial

The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a phase III trial.

Study links glucose time series complexity to diabetes progression

Weiping Jia et al., at Shanghai Jiao Tong University School of Medicine Affiliated Sixth People’s Hospital, China, conducted a study to explore the relationship between

April 9, 2024

Guideline renewal and more openness needed toward new digital contraceptive methods

New digital contraceptive methods, such as apps or wearables to determine fertile days, are gaining in popularity.

January 29, 2024

FDA’s proposed ban of electric shock devices has taken too long, autism advocates say

When Eagle visited the Judge Rotenberg Educational Center in a suburb south of Boston, with her mother in the early 2000s, the 14-year-old stepped into

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.